Up-to-date announcements, stories and opinion pieces from The AAS and researchers that we fund
Top This Week
Friday, October 30, 2020
The true cost of doing research in African institutions
Teenagers drive TB awareness in Botswana
Addressing Long Term Care for Nigeria’s Aging Population
Africa in a ‘sweet spot’ to lead global collaborations
Strengthening the Capacity of Africa’s Science Granting Councils in Research Management
Barriers to malaria interventions in Ghana
Harnessing solar power to provide clean energy
Non-renewable energy from fossil fuels such as coal, gas and oil are used widely across the globe and particularly in Africa. Fossil fuels generate greenhouse gases responsible for global warming. This environmental problem and the ever-increasing demand for energy, has motivated researchers to look for alternative renewable energy sources.
Developing affordable titanium implants in Africa
Titanium alloys are coveted in a wide range of land-based applications especially in the biomedical industry where they are used for making implants and prostheses. Around 80 million people in Africa are considered disabled and this is likely to increase with an increasingly aging population. Accidents and their resultant injuries have contributed to a high prevalence of disability and significant impacts on quality of life in Africa. Producing implants and prostheses locally would help in tackling this disability burden.
The voices missing from South Africa’s response to COVID-19
(courtesy: THE CONVERSATION)
Ten days after South Africa reported its first case of COVID-19 on 5 March 2020, the government moved quickly to declare a national state of disaster. Within days a National Coronavirus Command Council had been formed, travel restrictions imposed and schools closed. A national lockdown was announced on 23 March. This remains in force though restrictions are being lifted slowly.
Enhancing collaboration to strengthen Africa`s clinical trial capacity through an online platform
Without a cure or vaccine for COVID-19, it is likely the virus will continue to cause more deaths across the world. As of June 10, 2020, there are more than 1,096 COVID-19 clinical trials in the world and these numbers are changing rapidly. Only 35 (3%) are in Africa according to clinicaltrials.gov, PACTR and COVID-19 Trial Tracker. However, the African scientific community is adapting to the rapidly changing COVID-19 environment by readying themselves to conduct both drug and vaccine focused clinical trials. This has been possible in part because the number of COVID-19 cases remains low in Africa giving the community an opportunity to plan, improve processes and define new ways of doing things under COVID-19 instigated lock downs that have been implemented across the continent.
From Africa to the World: Connecting African innovators and ideas to industry
There is a disconnect between industry, angel donors, venture capitalists and research in Africa. This has resulted in few Research and Development (R&D) outputs being scaled up or commercialized and a negligible number of patents at 0.6 percent, according to the World Intellectual Property Organization. The lack of funding also compounds the challenge meaning that quite often African innovations will rarely grow beyond just being an idea or prototype in the laboratories.
The African Academy of Sciences (AAS) today announced the launch of an innovative platform for African innovators to connect with partners who can provide funding, help them scale-up and commercialize their innovations or promote their uptake in policy.
Making an impact through an innovation ecosystem to enhance Improved lives in Africa
Simon Ndoria, Programme Officer at Grand Challenges Africa (GC Africa), presents the Grand Challenges Innovation Network, a virtual network that launched today for African innovators and innovation support partners...